HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chiara Colombo Selected Research

Aggressive Fibromatosis (Desmoid)

1/2021The Prognostic Role of β-Catenin Mutations in Desmoid-type Fibromatosis Undergoing Resection Only: A Meta-analysis of Individual Patient Data.
1/2021Magnetic resonance imaging patterns of tumor response to chemotherapy in desmoid-type fibromatosis.
1/2020Familial adenomatosis polyposis-related desmoid tumours treated with low-dose chemotherapy: results from an international, multi-institutional, retrospective analysis.
11/2017β-Catenin in desmoid-type fibromatosis: deep insights into the role of T41A and S45F mutations on protein structure and gene expression.
3/2017Long-term Efficacy of Methotrexate Plus Vinblastine/Vinorelbine in a Large Series of Patients Affected by Desmoid-Type Fibromatosis.
1/2016Tailored Beta-catenin mutational approach in extra-abdominal sporadic desmoid tumor patients without therapeutic intervention.
12/2015Hormonal manipulation with toremifene in sporadic desmoid-type fibromatosis.
10/2013CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation study.
12/2011Increased midkine expression correlates with desmoid tumour recurrence: a potential biomarker and therapeutic target.
8/2011'Difficult to diagnose' desmoid tumours: a potential role for CTNNB1 mutational analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chiara Colombo Research Topics

Disease

24Neoplasms (Cancer)
03/2021 - 01/2005
10Sarcoma (Soft Tissue Sarcoma)
03/2021 - 12/2010
10Aggressive Fibromatosis (Desmoid)
01/2021 - 08/2011
5Fibroma (Fibromatosis)
01/2021 - 12/2015
4Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
08/2019 - 12/2010
2Neoplasm Metastasis (Metastasis)
01/2022 - 07/2013
2Melanoma (Melanoma, Malignant)
02/2015 - 01/2005
2Disease Progression
02/2015 - 01/2012
2Kidney Calculi (Kidney Stone)
07/2014 - 11/2010
2Leiomyosarcoma
07/2013 - 12/2010
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2012 - 01/2010
2Osteosarcoma (Osteogenic Sarcoma)
01/2012 - 09/2011
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2022
1Pneumonia (Pneumonitis)
01/2022
1COVID-19
01/2022
1Lymphoma (Lymphomas)
12/2021
1Fatigue
11/2021
1Liposarcoma
03/2021
1Malnutrition (Nutritional Deficiencies)
06/2020
1Beriberi
01/2020
1Morbid Obesity
01/2020
1Wernicke Encephalopathy (Wernicke's Encephalopathy)
01/2020
1Refeeding Syndrome
01/2020
1Chondrosarcoma
01/2019
1Bone Fractures (Bone Fracture)
01/2019
1Muscle Spasticity (Spastic)
08/2018
1Cardiovascular Diseases (Cardiovascular Disease)
08/2018
1Inflammation (Inflammations)
11/2017
1Arterial Occlusive Diseases (Arterial Occlusive Disease)
09/2016
1Dermatofibrosarcoma
01/2016
1Pain (Aches)
12/2015
1Residual Neoplasm
02/2015
1Clear Cell Sarcoma
02/2015
1Extraskeletal Myxoid Chondrosarcoma
12/2013

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
06/2020 - 01/2005
5CateninsIBA
01/2021 - 08/2011
4Methotrexate (Mexate)FDA LinkGeneric
01/2021 - 09/2011
4Biomarkers (Surrogate Marker)IBA
11/2017 - 12/2011
3SurvivinIBA
03/2021 - 12/2011
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2013 - 12/2011
2Doxorubicin (Adriamycin)FDA LinkGeneric
03/2021 - 07/2019
2Vinca AlkaloidsIBA
01/2021 - 03/2017
2Sunitinib (Sutent)FDA Link
06/2018 - 02/2015
2Formaldehyde (Formol)FDA Link
01/2016 - 07/2013
2AntigensIBA
02/2015 - 01/2005
2Neoplasm Antigens (Tumor Antigens)IBA
02/2015 - 01/2005
2MART-1 AntigenIBA
02/2015 - 01/2005
2Differentiation AntigensIBA
02/2015 - 01/2005
2weddelliteIBA
07/2014 - 11/2010
2Calcium OxalateIBA
07/2014 - 11/2010
2Imatinib Mesylate (Gleevec)FDA Link
12/2011 - 12/2010
1HydrogenIBA
11/2021
1VanadiumIBA
11/2021
1selinexorIBA
03/2021
1AlkaloidsIBA
01/2020
1Thiamine (Aneurin)FDA Link
01/2020
1Tyrosine Kinase InhibitorsIBA
08/2019
1IfosfamideFDA LinkGeneric
07/2019
1GemcitabineFDA Link
07/2019
1Semaphorins (Semaphorin)IBA
01/2019
1ElementsIBA
01/2019
1hydroxide ionIBA
08/2018
1Vitamin DFDA LinkGeneric
08/2018
1Type A Botulinum Toxins (Botox)FDA Link
08/2018
1DNA (Deoxyribonucleic Acid)IBA
04/2018
1Vinblastine (Vinblastine Sulfate)FDA Link
03/2017
1Vinorelbine (Navelbine)FDA LinkGeneric
03/2017
1Succinate Dehydrogenase (Fumarate Reductase)IBA
01/2017
1antineoplaston A10 (A 10)IBA
01/2016
1beta CateninIBA
01/2016
1Transforming Growth Factor beta (TGF-beta)IBA
12/2015
1Toremifene (Fareston)FDA Link
12/2015
1Calmodulin-Binding Proteins (Caldesmon)IBA
03/2015
1DesminIBA
03/2015
1CalponinsIBA
03/2015
1MyogeninIBA
03/2015
1whewelliteIBA
07/2014
1AnthracyclinesIBA
12/2013
1Serine (L-Serine)FDA Link
10/2013
1Codon (Codons)IBA
10/2013
1Cadherins (E-Cadherin)IBA
10/2013
1Phenylalanine (L-Phenylalanine)FDA Link
10/2013
1ParaffinIBA
07/2013
1Hormones (Hormone)IBA
07/2013
1Perilipin-2IBA
05/2013

Therapy/Procedure

7Drug Therapy (Chemotherapy)
12/2021 - 11/2012
7Therapeutics
03/2021 - 09/2011
5Radiotherapy
06/2018 - 03/2010
2Hyperthermic Intraperitoneal Chemotherapy
04/2015 - 12/2010
1Continuous Positive Airway Pressure
01/2022
1Surgical Amputation (Amputations)
01/2022
1Operative Surgical Procedures
02/2021
1Nutritional Support (Artificial Feeding)
06/2020
1Gastrectomy
01/2020
1Bariatric Surgery
01/2020
1Laparotomy
10/2019
1Prostheses and Implants (Prosthesis)
09/2016
1Embolectomy
09/2016
1Catheters
09/2016
1Metastasectomy
07/2013